Venture Challenge Fall 2025 now open – with two editions: Life Sciences & Health and MedTech!

The Venture Challenge Fall 2025 is officially open for applications — and this year, the Fall program features two separate editions. Applicants will participate in one edition only, based on the focus of their innovation:

  • Edition I is for Life Sciences & Health startups

  • Edition II is for MedTech startups

Thanks to additional funding from the Ministry of Economic Affairs, 12 teams in total will be selected — 6 for each edition. Selected teams will follow a high-impact, 8–10 week programme to turn their research into a solid business case with guidance from experienced coaches and sector experts.

 

Who can apply?

Teams of 3 to 4 people who:

  • Have founded, or plan to found, a startup in either Life Sciences & Health (Edition I) or MedTech (Edition II)

  • Are developing an innovative product, process, or service within these domains

  • Are based in the Netherlands and ready to build a business case with professional support

 

Which edition is right for you?

Edition I – Life Sciences & Health

  • Bootcamp 1: 1–3 October 2025

  • Bootcamp 2: 5–7 November 2025

  • Jury pitches: 19 November 2025

  • (Award ceremony will take place on the Dutch Life Siences Conferences)

Edition II – MedTech

  • Bootcamp 1: 26–28 November 2025

  • Bootcamp 2: 21–23 January 2026

  • Jury pitches: 11 February 2026

  • (Award ceremony will take place on the Innovation4Health conference)

Note: you will only attend the programme dates that match your assigned edition. Teams are selected for one edition based on their innovation focus.

 

Program details

  • 12 total teams (6 per edition)

  • Programme duration: 8–10 weeks including two bootcamps and a final pitch

  • Grant ceiling: €200,000

  • Own contribution:
    €2,000 (3 team members)
    €2,500 (4 team members)

  • Deadline to apply: 1 July 2025, 14:00 CET

  • Organised by: NWO in collaboration with Health~Holland and Holland High Tech

Ready to take the leap from research to real-world impact?

Apply now

vc

‹ News overview